septembre 2020
Remedy, a portfolio company of Topspin Consumer Partners, has acquired OBR
Financial Advisor to Neuronetics on its Announced Merger with Greenbrook TMS
Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma
Exclusive Financial Advisor (Buy side)
